Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Double-blind study of tadalafil in pediatric pulmonary arterial hypertension
2012-002354-23Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jan 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tadalafil in pulmonary arterial hypertension (PAH) (2 arms), sponsored by Eli Lilly and Company. Primary endpoint: Time to first occurrence of clinical worsening. Started Jan 2013; status: completed.
02
Drugs
tadalafil
03
Conditions
pulmonary arterial hypertension (PAH)
Beyond the preview
Go deeper on 2012-002354-23.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002354-23.